174 related articles for article (PubMed ID: 31881861)
1. Risk factors for vancomycin-resistant enterococcus acquisition during a large outbreak in patients aged 65 years and older.
Mathis B; Haïne M; Girard R; Bonnefoy M
BMC Geriatr; 2019 Dec; 19(1):377. PubMed ID: 31881861
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with Vancomycin-resistant Enterococcus acquisition during a large outbreak.
Fossi Djembi L; Hodille E; Chomat-Jaboulay S; Coudrais S; De Santis N; Gardes S; Mauranne CC; Mourey N; Fredenucci I; Girard R
J Infect Public Health; 2017; 10(2):185-190. PubMed ID: 27140696
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.
Flokas ME; Karageorgos SA; Detsis M; Alevizakos M; Mylonakis E
Int J Antimicrob Agents; 2017 May; 49(5):565-572. PubMed ID: 28336313
[TBL] [Abstract][Full Text] [Related]
4. The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.
Zhou MJ; Li J; Salmasian H; Zachariah P; Yang YX; Freedberg DE
J Hosp Infect; 2019 Jan; 101(1):69-75. PubMed ID: 30026006
[TBL] [Abstract][Full Text] [Related]
5. Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients.
Lewis JD; Barros AJ; Sifri CD
Transpl Infect Dis; 2018 Jun; 20(3):e12856. PubMed ID: 29427322
[TBL] [Abstract][Full Text] [Related]
6. Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation.
Nourse C; Murphy H; Byrne C; O'Meara A; Breatnach F; Kaufmann M; Clarke A; Butler K
Eur J Pediatr; 1998 Jan; 157(1):20-7. PubMed ID: 9461358
[TBL] [Abstract][Full Text] [Related]
7. EPIDEMIOLOGY AND CONTROL OF THE FIRST REPORTED VANCOMYCIN-RESISTANT ENTEROCOCCUS OUTBREAK AT A TERTIARY-CARE HOSPITAL IN BANGKOK, THAILAND.
Chotiprasitsakul D; Santanirand P; Thitichai P; Rotjanapan P; Watcharananan S; Siriarayapon P; Chaihongsa N; Sirichot S; Chitasombat M; Chantharit P; Malathum K
Southeast Asian J Trop Med Public Health; 2016 May; 47(3):494-502. PubMed ID: 27405133
[TBL] [Abstract][Full Text] [Related]
8. Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
Lee SC; Lee CW; Shih TC; See LC; Chu CM; Liu YC
J Microbiol Immunol Infect; 2016 Oct; 49(5):749-759. PubMed ID: 27156242
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital.
Zhou Q; Moore C; Eden S; Tong A; McGeer A;
Infect Control Hosp Epidemiol; 2008 May; 29(5):398-403. PubMed ID: 18419360
[TBL] [Abstract][Full Text] [Related]
10. [Interventions implemented to control an outbreak of vancomycin-resistant enterococci in a university hospital].
Henard S; Cao-Huu T; Loos-Ayav C; Chanet P; Kessler M; Rabaud C
Nephrol Ther; 2009 Jun; 5 Suppl 4():S265-71. PubMed ID: 19596347
[TBL] [Abstract][Full Text] [Related]
11. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
[TBL] [Abstract][Full Text] [Related]
12. Comparative Epidemiology of Vancomycin-Resistant Enterococci Colonization in an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term Care Facilities in Singapore.
Tan D; Htun HL; Koh J; Kanagasabai K; Lim JW; Hon PY; Ang B; Chow A
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224534
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors and Outcomes of Vancomycin-Resistant
Yeung CS; Cheung CY; Chan YH; Chak WL
Perit Dial Int; 2017; 37(5):556-561. PubMed ID: 28348103
[TBL] [Abstract][Full Text] [Related]
15. [Control measures for a VRE outbreak in a haemodialysis unit].
Diguio N; Chanet P; Hautemanière A; Cao-Huu T; Hartemann P; Kessler M
Nephrol Ther; 2009 Jun; 5 Suppl 4():S272-80. PubMed ID: 19596348
[TBL] [Abstract][Full Text] [Related]
16. An outbreak of vanA vancomycin-resistant Enterococcus faecium in a hospital with endemic vanB VRE.
Hughes A; Ballard S; Sullivan S; Marshall C
Infect Dis Health; 2019 May; 24(2):82-91. PubMed ID: 30638872
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin-resistant enterococci (VRE) outbreak at a university hospital in Kitakyushu, Japan: case-control studies.
Hoshuyama T; Moriguchi H; Muratani T; Matsumoto T
J Infect Chemother; 2008 Oct; 14(5):354-60. PubMed ID: 18936888
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.
Webb BJ; Healy R; Majers J; Burr Z; Gazdik M; Lopansri B; Hoda D; Petersen FB; Ford C
Clin Infect Dis; 2017 Jun; 64(12):1753-1759. PubMed ID: 28369204
[TBL] [Abstract][Full Text] [Related]
19. 2004 Lowbury Lecture: the Western Australian experience with vancomycin-resistant enterococci - from disaster to ongoing control.
Pearman JW
J Hosp Infect; 2006 May; 63(1):14-26. PubMed ID: 16563562
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine.
Heisel RW; Sutton RR; Mascara GP; Winger DG; Weber DR; Lim SH; Oleksiuk LM
Leuk Lymphoma; 2017 Nov; 58(11):2565-2572. PubMed ID: 28351179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
